Argenx
ARGX
#526
Rank
S$60.34 B
Marketcap
S$975.13
Share price
-5.59%
Change (1 day)
17.01%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

ESG Reports

Thumbnail Argenx
 ESG Report 2023

ESG Report 2023

Language: English

View ESG Report
Thumbnail Argenx
 ESG Report 2022

ESG Report 2022

Language: English

View ESG Report
Thumbnail Argenx
 ESG Report 2021

ESG Report 2021

Language: English

View ESG Report